相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。New Therapeutic Targets in Idiopathic Pulmonary Fibrosis Aiming to Rein in Runaway Wound-Healing Responses
Neil Ahluwalia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Negative Regulation of NADPH Oxidase 4 by Hydrogen Peroxide-inducible Clone 5 (Hic-5) Protein
Leena P. Desai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SWIAD-dependent profibrotic signaling
Xiwu Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
Meng Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis
Lutz Wollin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Insufficient autophagy in idiopathic pulmonary fibrosis
Jun Araya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Decreased expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis fibroblasts
Alberto Ricci et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
Yong Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
Autophagic action of new targeting agents in head and neck oncology
Hidemi Rikiishi
CANCER BIOLOGY & THERAPY (2012)
Autophagy in Idiopathic Pulmonary Fibrosis
Avignat S. Patel et al.
PLOS ONE (2012)
Autophagy An 'Achilles' heel of tumorigenesis in TSC and LAM
Jane Yu et al.
AUTOPHAGY (2011)
Reversible differentiation of myofibroblasts by MyoD
Louise Hecker et al.
EXPERIMENTAL CELL RESEARCH (2011)
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors
Bruno Calabretta et al.
LEUKEMIA & LYMPHOMA (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
Weidong Han et al.
PLOS ONE (2011)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
N. I. Chaudhary et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion
Amy J. Galliher et al.
CANCER RESEARCH (2007)
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: Implications for treatment of fibrotic diseases
Ragini Vittal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice
Y Aono et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Mechanisms of pulmonary fibrosis
VJ Thannickal et al.
ANNUAL REVIEW OF MEDICINE (2004)
Regulation of serum-induced fibronectin expression by protein kinases, cytoskeletal integrity, and CREB
JE Michaelson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
How cells read TGF-β signals
J Massagué
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)